DPP-4-话题@MedSci

#DPP-4#

57篇内容 | 2189人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1401935, encodeId=3f771401935cc, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益, objectType=article, longId=86450, objectId=3a6086450fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a6086450fa, replyNumber=0, likeNumber=61, createdTime=2017-01-05, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a6086450fa, moduleTitle=造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a6086450fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401934, encodeId=64091401934ff, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=DPP-4抑制剂多重获益，助力中国2型糖尿病管理, objectType=article, longId=83314, objectId=68c383314af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68c383314af, replyNumber=0, likeNumber=59, createdTime=2016-12-01, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68c383314af, moduleTitle=DPP-4抑制剂多重获益，助力中国2型糖尿病管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68c383314af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401933, encodeId=af8d1401933d0, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Heart：使用DPP-4抑制剂可降低心血管事件发生的风险, objectType=article, longId=81562, objectId=615781562ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615781562ab, replyNumber=0, likeNumber=64, createdTime=2016-11-02, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615781562ab, moduleTitle=Heart：使用DPP-4抑制剂可降低心血管事件发生的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615781562ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401932, encodeId=406d140193278, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, objectType=article, longId=69403, objectId=04f76940319, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04f76940319, replyNumber=0, likeNumber=63, createdTime=2016-05-30, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04f76940319, moduleTitle=阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04f76940319)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401931, encodeId=c5b8140193180, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetes Care：2型糖尿病患者使用DPP-4与心衰入院没有联系, objectType=article, longId=69029, objectId=d7776902991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7776902991, replyNumber=0, likeNumber=86, createdTime=2016-05-25, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7776902991, moduleTitle=Diabetes Care：2型糖尿病患者使用DPP-4与心衰入院没有联系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7776902991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401930, encodeId=22241401930b0, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险, objectType=article, longId=67469, objectId=36856e46917, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36856e46917, replyNumber=0, likeNumber=62, createdTime=2016-05-05, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36856e46917, moduleTitle=BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36856e46917)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401929, encodeId=eba81401929dc, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=J Am Med Dir Assoc：老年糖尿病患者应用DPP-4is可改善心血管预后, objectType=article, longId=61175, objectId=dda2611e5b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dda2611e5b0, replyNumber=0, likeNumber=49, createdTime=2015-12-28, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dda2611e5b0, moduleTitle=J Am Med Dir Assoc：老年糖尿病患者应用DPP-4is可改善心血管预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dda2611e5b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401928, encodeId=337c1401928c2, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, objectType=article, longId=60556, objectId=f8216055671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8216055671, replyNumber=0, likeNumber=62, createdTime=2015-12-14, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8216055671, moduleTitle=CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8216055671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401927, encodeId=c26e140192eaa, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低, objectType=article, longId=57839, objectId=c59a5e83922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c59a5e83922, replyNumber=0, likeNumber=89, createdTime=2015-10-28, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c59a5e83922, moduleTitle=AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c59a5e83922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401926, encodeId=de4b1401926a6, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）, objectType=article, longId=51869, objectId=15cd51869b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15cd51869b4, replyNumber=0, likeNumber=69, createdTime=2015-06-11, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15cd51869b4, moduleTitle=ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15cd51869b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401925, encodeId=384a140192520, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生, objectType=article, longId=49858, objectId=d38d4985820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d38d4985820, replyNumber=0, likeNumber=61, createdTime=2015-04-26, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d38d4985820, moduleTitle=Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d38d4985820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401924, encodeId=cc991401924d8, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗, objectType=article, longId=29669, objectId=5e1f2966944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e1f2966944, replyNumber=0, likeNumber=67, createdTime=2014-01-22, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e1f2966944, moduleTitle=合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e1f2966944)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401923, encodeId=9281140192394, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=DPP-4抑制剂可在糖尿病治疗领域“大显身手”, objectType=article, longId=29457, objectId=b5582945e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5582945e78, replyNumber=0, likeNumber=0, createdTime=2014-01-17, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5582945e78, moduleTitle=DPP-4抑制剂可在糖尿病治疗领域“大显身手”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5582945e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401922, encodeId=71f1140192259, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药, objectType=article, longId=27157, objectId=fec72e15705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fec72e15705, replyNumber=0, likeNumber=96, createdTime=2013-11-28, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fec72e15705, moduleTitle=CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fec72e15705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401921, encodeId=815614019214b, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=ESC 2013：DPP-4抑制剂类糖尿病药物未增加心血管风险, objectType=article, longId=23763, objectId=6d0923e6314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d0923e6314, replyNumber=0, likeNumber=71, createdTime=2013-09-05, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d0923e6314, moduleTitle=ESC 2013：DPP-4抑制剂类糖尿病药物未增加心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d0923e6314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401920, encodeId=e1e214019200b, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=DPP-4抑制剂：破解2型糖尿病的治疗困境, objectType=article, longId=3240, objectId=3abf324041, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3abf324041, replyNumber=0, likeNumber=96, createdTime=2011-11-02, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3abf324041, moduleTitle=DPP-4抑制剂：破解2型糖尿病的治疗困境, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3abf324041)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1401919, encodeId=609e140191909, content=<a href='/topic/show?id=7ff0621125' target=_blank style='color:#2F92EE;'>#DPP-4#</a>, objectTitle=FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin, objectType=article, longId=2606, objectId=f8c826063a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8c826063a, replyNumber=0, likeNumber=94, createdTime=2011-06-03, rootId=0, userName=gaoxiaoe, userId=eeb42370314, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8c826063a, moduleTitle=FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8c826063a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

DPP-4

2020-05-29

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

造福老年2型糖尿病人群，DPP-4抑制剂西格列汀让更多患者受益

2017-01-05

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

DPP-4抑制剂多重获益，助力中国2型糖尿病管理

2016-12-01

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Heart：使用DPP-4抑制剂可降低心血管事件发生的风险

2016-11-02

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

阿斯利康降糖药saxa/dapa（沙格列汀/达格列净）获欧盟CHMP支持批准，将成欧洲DPP-4i/SGLT-2i降糖药

2016-05-30

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetes Care：2型糖尿病患者使用DPP-4与心衰入院没有联系

2016-05-25

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

BMJ：DPP-4抑制剂加磺酰脲类药物与低血糖风险

2016-05-05

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

J Am Med Dir Assoc：老年糖尿病患者应用DPP-4is可改善心血管预后

2015-12-28

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

CDS 2015：洪天配解读DPP-4抑制剂与SGLT-2抑制剂在糖尿病治疗中的协同作用

2015-12-14

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

AIM：DPP-4抑制剂治疗T2DM心衰患者可将风险降到很低

2015-10-28

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

ADA 2015：DPP-4抑制剂西格列汀心血管安全性良好（TECOS研究）

2015-06-11

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

Diabetologia：DPP-4抑制剂可通过GIP-胰高血糖素负反馈轴阻止低血糖发生

2015-04-26

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

合并心衰的2型糖尿病患者还能用DPP-4抑制剂吗

2014-01-22

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

DPP-4抑制剂可在糖尿病治疗领域“大显身手”

2014-01-17

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

CDS 2013：杨文英认为DPP-4抑制剂是“智能化”降糖药

2013-11-28

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

ESC 2013：DPP-4抑制剂类糖尿病药物未增加心血管风险

2013-09-05

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

DPP-4抑制剂：破解2型糖尿病的治疗困境

2011-11-02

gaoxiaoe (审核中...)

前往app查看评论内容

#DPP-4#

FDA批准2型糖尿病治疗新药DPP-4抑制剂Linagliptin

2011-06-03

科室
- - 订阅+
  - 更多科室
工具
服务